Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript March 14, 2024 Quoin Pharmaceuticals, Ltd.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Stonepine Capital Timothy P. Lynch | 252,434 | $1,151,099 | +27% | 0.72% |
| 2. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 236,234 | $1,077,227 | 0.15% | |
| 3. | StemPoint Capital Michelle Ross | 236,234 | $1,077,227 | 0.19% | |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 236,234 | $1,077,227 | 0.03% | |
| 5. | AIGH Investment Partners Orin Hirschman | 236,234 | $1,077,227 | +238% | 0.11% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.88 | 20,490 | $99,991.20 | 37,709 | 2026-08-31 | Filing | |
| $4.88 | 20,490 | $99,991.20 | 37,713 | 2026-08-31 | Filing | |
| $4.88 | 10,244 | $49,990.72 | 10,684 | 2026-08-31 | Filing | |
| $4.88 | 6,146 | $29,992.48 | 40,364 | 2026-08-31 | Filing | |
| $8.49 | 15,152 | $128,640.48 | 15,153 | 2025-10-14 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.73 | 297 | $217.40 | 53 | 2024-06-07 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 204,910 | $934,390 | 0.97% | |
| 2. | 193,937 | $884,353 | 0.9% | |
| 3. | 190,192 | $867,276 | 0.02% | |
| 4. | 59,838 | $272,861 | 0% | |
| 5. | 50,000 | $228,000 | 0.16% |